Screener
Alto Neuroscience ANRO Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Alto Neuroscience’s reported figures.
Based on the most recent quarter.
The source filing: Alto Neuroscience’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001999480-26-000012
FAQ
- What is Alto Neuroscience's debt-to-equity?
- Alto Neuroscience (ANRO) reported debt-to-equity of 0.1× in Q1 2026.
- How has Alto Neuroscience's debt-to-equity changed year-over-year?
- Alto Neuroscience's debt-to-equity decreased by 52.7% year-over-year, from 0.2× to 0.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Alto Neuroscience's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude